The role of overdiagnosis and reclassification in the marked increase of esophageal adenocarcinoma incidence

Journal of the National Cancer Institute

Volumn 97, Issue 2, 2005, Pages 142-146

  Pohl, Heiko ^a   Welch, H Gilbert ^a,b  

^a VA MEDICAL CENTER   (United States)

^b DARTMOUTH MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BREAST CANCER; CANCER CLASSIFICATION; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER LOCALIZATION; CANCER MORTALITY; CANCER PATIENT; CANCER STAGING; DATA BASE; ESOPHAGEAL ADENOCARCINOMA; HUMAN; MELANOMA; PRIORITY JOURNAL; PROSTATE CANCER; SQUAMOUS CELL CARCINOMA; UNITED STATES; ADENOCARCINOMA; ADULT; AGED; CANCER REGISTRY; CLASSIFICATION; COST OF ILLNESS; CROSS-SECTIONAL STUDY; DIAGNOSTIC ERROR; DIFFERENTIAL DIAGNOSIS; EPIDEMIOLOGY; ESOPHAGUS TUMOR; FEMALE; INCIDENCE; MALE; METHODOLOGY; MIDDLE AGED; MORTALITY; RISK FACTOR;

ADENOCARCINOMA; ADULT; AGED; CLASSIFICATION; CONFOUNDING FACTORS (EPIDEMIOLOGY); COST OF ILLNESS; CROSS-SECTIONAL STUDIES; DIAGNOSIS, DIFFERENTIAL; DIAGNOSTIC ERRORS; ESOPHAGEAL NEOPLASMS; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; RISK FACTORS; SEER PROGRAM; UNITED STATES;

EID: 13744258445     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/dji024     Document Type: Article

References (22)

1. Jemal A, Tiwari RC, Murray T, Ghafoor A, Samuels A, Ward E, et al. Cancer statistics, 2004. CA Cancer J Clin 2004;54:8-29.
2. Devesa SS, Blot WJ, Fraumeni JF Jr. Changing patterns in the incidence of esophageal and gastric carcinoma in the United States. Cancer 1998;83: 2049-53.
3. El-Serag HB, Mason AC, Petersen N, Key CR. Epidemiological differences between adenocarcinoma of the oesophagus and adenocarcinoma of the gastric cardia in the USA. Gut 2002;50:368-72.
4. Blot WJ, Devesa SS, Kneller RW, Fraumeni IF Jr. Rising incidence of adenocarcinoma of the esophagus and gastric cardia. JAMA 1991;265: 1287-9.
5. Brown LM, Devesa SS. Epidemiologic trends in esophageal and gastric cancer in the United States. Surg Oncol Clin North Am 2002;11:235-56.
6. Black WC. Overdiagnosis: an underrecognized cause of confusion and harm in cancer screening. J Natl Cancer Inst 2000;92:1280-2.
7. Etzioni R, Penson DF, Legler JM, di Tommaso D, Boer R, Gann PH, et al. Overdiagnosis due to prostate-specific antigen screening: lessons from U.S. prostate cancer incidence trends. J Natl Cancer Inst 2002;94:981-90.
8. Schwartz LM, Woloshin S, Welch HG. Trends in diagnostic testing following a national guideline for evaluation of dyspepsia. Arch Intern Med 1996;156:873-5.
9. Benhamiche AM, Faivre J, Tazi AM, Couillault C, Villing AL, Rat P. Time trends in diagnostic strategy, treatment, and prognosis of gastric cancer in the elderly: a population based study. Eur J Cancer Prev 1997;6:71-7.
10. Eloubeidi MA, Mason AC, Desmond RA, El-Serag HB. Temporal trends (1973-1997) in survival of patients with esophageal adenocarcinoma in the United States: a glimmer of hope? Am J Gastroenterol 2003;98:1627-33.
11. Younes M, Henson DE, Ertan A, Miller CC. Incidence and survival trends of esophageal carcinoma in the United States: racial and gender differences by histological type. Scand J Gastroenterol 2002;37:1359-65.
12. El-Serag HB. The epidemic of esophageal adenocarcinoma. Gastroenterol Clin North Am 2002;31:421-40, viii.
13. Botterweck AA, Schouten LJ, Volovics A, Dorant E, van Den Brandt PA. Trends in incidence of adenocarcinoma of the oesophagus and gastric cardia in ten European countries. Int J Epidemiol 2000;29:645-54.
14. Ekstrom AM, Signorello LB, Hansson LE, Bergstrom R, Lindgren A, Nyren O. Evaluating gastric cancer misclassification: a potential explanation for the rise in cardia cancer incidence. J Natl Cancer Inst 1999;91: 786-90.
15. Kubo A, Corley DA. Marked multi-ethnic variation of esophageal and gastric cardia carcinomas within the United States. Am J Gastroenterol 2004;99:582-8.
16. Available at http://seer.cancer.gov/training/ and http://seer.cancer.gov/about/quality.html.
17. Lagergren J, Bergstrom R, Lindgren A, Nyren O. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med 1999;340:825-31.
18. Cheng KK, Sharp L, McKinney PA, Logan RE, Chilvers CE, Cook-Mozaffari P, et al. A case-control study of oesophageal adenocarcinoma in women: a preventable disease. Br J Cancer 2000;83:127-32.
19. Lagergren J, Bergstrom R, Nyren O. Association between body mass and adenocarcinoma of the esophagus and gastric cardia. Ann Intern Med 1999;130:883-90.
20. Brown LM, Swanson CA, Gridley G, Swanson GM, Schoenberg JB, Greenberg RS, et al. Adenocarcinoma of the esophagus: role of obesity and diet. J Natl Cancer Inst 1995;87:104-9.
21. Blaser MJ. Hypothesis: the changing relationships of Helicobacter pylori and humans: implications for health and disease. J Infect Dis 1999;179: 1523-30.
22. Graham DY. The changing epidemiology of GERD: geography and Helicobacter pylori. Am J Gastroenterol 2003;98:1462-70.